News & Perspective

Apr 14, 2017

Apr 14, 2017
Ebola worker

Huge genome study dissects Ebola outbreak's spread

About 4% of patients traveled, a potential target for curbing disease spread.

Apr 06, 2017

Apr 06, 2017
Ebola vaccine trial

Large trial launches of different Ebola vaccine strategies

The phase 2 trials will enroll more than 5,000 adults and kids in Guinea and Liberia.

Jan 18, 2017

Jan 18, 2017

News Scan for Jan 18, 2017

Brazil mosquito control
Lingering Ebola symptoms
More chikungunya
Antimicrobial-coated sutures
Center for Health Security move

Jan 11, 2017

Jan 11, 2017

News Scan for Jan 11, 2017

Saudi MERS case
Newborn survives Ebola

Dec 27, 2016

Dec 27, 2016
Map of Africa

Ebola vaccine highly effective in final trial results

In addition, phase 2 trial of an adenovirus-based vaccine shows it to be safe and immunogenic though protection less than prolonged. 

Dec 12, 2016

Dec 12, 2016

News Scan for Dec 12, 2016

Ebola in breastmilk, semen
Colistin-resistant Klebsiella
Anthrax vaccine funds
Low chikungunya numbers
Creutzfeldt-Jakob test

Nov 15, 2016

Nov 15, 2016
Ebola treatment unit

Mild Ebola cases may mean outbreak larger than thought

About 7.5% of close contacts tested positive, while another study dissected convalescent plasma use.

Oct 31, 2016

Oct 31, 2016

News Scan for Oct 31, 2016

Saudi MERS case
Ebola transmission
Organic food outbreaks
Chikungunya blip

Oct 12, 2016

Oct 12, 2016
ZMapp Ebola drug research

Trial offers mixed view of Ebola drug ZMapp

"I would view the results . . . in an optimistic light," said lead author Richard Davey after the drug showed more than 90% efficacy.

Sep 20, 2016

Sep 20, 2016

News Scan for Sep 20, 2016

MERS in Austria
Global flu update
Triclosan-containing sutures
Ebola strain comparison

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»